GenVec Inc.'s CEO To Participate In Panel Session On Pancreatic Cancer Treatment Strategies At The Biotechnology Industry Organization (BIO) CEO & Investor Conference

GAITHERSBURG, Md.--(BUSINESS WIRE)--Feb. 10, 2006--GenVec, Inc. (Nasdaq:GNVC) announced today that Paul H. Fischer, Ph.D., president and chief executive officer of GenVec, will participate in a panel session at the 8th Annual BIO CEO & Investor Conference in New York, NY entitled, “A Glimmer of Hope - Pancreatic Cancer Treatment Strategies.” The panel session will be broadcast live over the internet on Wednesday, February 15, 2006 at 8:30 a.m. EST.

MORE ON THIS TOPIC